1st Quarter - Report — HOOPER, LUNDY & BOOKMAN, P.C. for ROCHE DIAGNOSTICS CORPORATION (2022)

Firm

HOOPER, LUNDY & BOOKMAN, P.C.

Client

ROCHE DIAGNOSTICS CORPORATION

Income

$50,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; H.R. 3463/S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021.

Lobbyist	Covered position, as disclosed
LISA LAYMAN	SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3463 (117th), S. 1693 (117th), H.R. 747 (117th), S. 1974 (117th), S. 1018 (117th)

Medical/Disease Research/Clinical Labs MED

H.R. 4128/S.2209, the Verifying Accurate Leading-edge IVCT Development Act of 2021 (the VALID Act of 2021).

Lobbyist	Covered position, as disclosed
LISA LAYMAN	SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4128 (117th), S. 2209 (117th)

Pharmacy PHA

S. 3799-PREVENT Pandemics Act

Lobbyist	Covered position, as disclosed
LISA LAYMAN	SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3799 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.